The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, W. J.
Right arrow Articles by Bennett, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, W. J.
Right arrow Articles by Bennett, M.

The Journal of Immunology, Vol 144, Issue 9 3305-3311, Copyright © 1990 by American Association of Immunologists


ARTICLES

An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells

WJ Murphy, V Kumar, JC Cope and M Bennett
Department of Pathology, University of Texas Southwestern Medical Center, Dallas 75235.

The mechanisms behind the increased incidence of marrow graft failure in recipients that receive allogeneic marrow depleted of T cells were studied. Recipient mice were lethally irradiated and challenged with bone marrow cells (BMC) from C.B-17 +/+ (+/+) donors. Radioisotope 125IUdR incorporation was assessed 5 to 7 days after transfer to determine the extent of engraftment. Some groups received BMC in which the T cells were removed by treatment with antibody and C. In addition, some groups received BMC from T cell-deficient C.B-17 scid/scid (SCID) mice to determine the postulated need for donor T cells in hematopoiesis and engraftment. In a model system that distinguishes between possible host NK cell and radioresistant T cell-mediated rejection of marrow allografts, it was determined that the absence of donor T cells in a marrow graft does not affect engraftment in syngeneic recipients. However, both host NK cell and radioresistant T cell rejection was markedly enhanced when SCID BMC or BMC from C.B-17 +/+ donors that had T cells removed by antibody and complement were infused into irradiated allogeneic recipients. Furthermore, the addition of alloreactive thymocytes as a source of T cells could abrogate this increased susceptibility of the BMC to host rejection mechanisms. As determined by histology and 59Fe uptake, the addition of thymocytes resulted in enhanced erythropoiesis. These results suggest that the increased incidence of marrow graft failure when BMC depleted of T cells are used is a result of active rejection by host effector cells and that the adverse effect of marrow T cell depletion can be reversed by the addition of thymocytes.


This article has been cited by other articles:


Home page
J. Immunol.Home page
K. Iizuka, A. A. Scalzo, H. Xian, and W. M. Yokoyama
Regulation of the NK Cell Alloreactivity to Bone Marrow Cells by the Combination of the Host NK Gene Complex and MHC Haplotypes
J. Immunol., March 1, 2008; 180(5): 3260 - 3267.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. Barao, A. M. Hanash, W. Hallett, L. A. Welniak, K. Sun, D. Redelman, B. R. Blazar, R. B. Levy, and W. J. Murphy
Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells
PNAS, April 4, 2006; 103(14): 5460 - 5465.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
A. J. Barrett, K. Rezvani, S. Solomon, A. M. Dickinson, X. N. Wang, G. Stark, H. Cullup, M. Jarvis, P. G. Middleton, and N. Chao
New Developments in Allotransplant Immunology
Hematology, January 1, 2003; 2003(1): 350 - 371.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. R. Drobyski, H. C. Morse III, W. H. Burns, J. T. Casper, and G. Sandford
Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene
Blood, April 15, 2001; 97(8): 2506 - 2513.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C.-k. Lee, K. Kim, L. A. Welniak, W. J. Murphy, K. Muegge, and S. K. Durum
Thymic emigrants isolated by a new method possess unique phenotypic and functional properties
Blood, March 1, 2001; 97(5): 1360 - 1369.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Urbano-Ispizua, C. Rozman, P. Pimentel, C. Solano, J. de la Rubia, S. Brunet, J. Perez-Oteiza, C. Ferra, J. Zuazu, D. Caballero, et al.
The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings
Blood, January 15, 2001; 97(2): 383 - 387.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. D. Shultz, P. A. Lang, S. W. Christianson, B. Gott, B. Lyons, S. Umeda, E. Leiter, R. Hesselton, E. J. Wagar, J. H. Leif, et al.
NOD/LtSz-Rag1null Mice: An Immunodeficient and Radioresistant Model for Engraftment of Human Hematolymphoid Cells, HIV Infection, and Adoptive Transfer of NOD Mouse Diabetogenic T Cells
J. Immunol., March 1, 2000; 164(5): 2496 - 2507.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Raziuddin, D. L. Longo, L. Mason, J. R. Ortaldo, M. Bennett, and W. J. Murphy
Differential Effects of the Rejection of Bone Marrow Allografts by the Depletion of Activating Versus Inhibiting Ly-49 Natural Killer Cell Subsets
J. Immunol., January 1, 1998; 160(1): 87 - 94.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.